RPM Welcomes Binu Panicker as Chief Technology Officer
BIRMINGHAM, Mich., Aug. 22, 2025 /PRNewswire/ — RPM is pleased to announce the appointment of Binu Panicker as the new Chief Technology Officer. Panicker brings... Read more.
Nota AI Files Securities Registration Statement, Poised for KOSDAQ Listing This Year
Swift IPO Process Amid Global Market Slowdown – Demonstrating Proven Competitiveness Business Expansion Driven by Proprietary Platform ‘NetsPresso®’... Read more.
AIRNET TECHNOLOGY INC. ANNOUNCES US$180.0 MILLION REGISTERED DIRECT OFFERING
BEIJING, Aug. 22, 2025 /PRNewswire/ — AirNet Technology Inc. (Nasdaq: ANTE) (“AirNet” or the “Company”), today announced that it has... Read more.
Bio-Thera and STADA Extend Biosimilars Alliance to Tocilizumab
Bio-Thera and STADA agree to extend their biosimilars alliance to cover tocilizumab, a targeted immunomodulatory monoclonal antibody directed against the interleukin-6... Read more.
Saroasis Studios Reveals Fate Trigger Early Access Date
COLOGNE, Germany, Aug. 22, 2025 /PRNewswire/ — Following a highly successful Closed Beta Test that drew in over hundreds of thousands of players shortly after... Read more.
The Realities of Working Motherhood in 2025 — and What Needs to Change
NEW YORK, Aug. 22, 2025 /PRNewswire/ — As parents prepare for the chaos of back-to-school season, millions of working mothers are juggling even more behind... Read more.
DeFi Technologies Announces Launch of Normal Course Issuer Bid
TORONTO, Aug. 22, 2025 /PRNewswire/ – DeFi Technologies Inc. (the “Company” or “DeFi Technologies“) (Nasdaq: DEFT) (CBOE CA: DEFI)... Read more.
Sonic Healthcare USA, Inc. Announces Acquisition of Cairo Diagnostics LLC to Expand Sonic’s National Hematology Oncology Testing Capabilities
WHITE PLAINS, N.Y. and DALLAS, Aug. 22, 2025 /PRNewswire/ — Sonic Healthcare USA, Inc. (“SHUSA” or “Sonic”) today announced it has... Read more.
zvoove Acquires Spain’s Market Leader for Temporary Staffing Solutions, Nivel IV
MUNICH and VIGO, Spain, Aug. 22, 2025 /PRNewswire/ — zvoove, the market leading software and AI solution provider for the temporary staffing, private security,... Read more.
Lighthouse Pharmaceuticals Receives $49.2 Million Grant from NIA to Advance Phase 2 Study of LHP588 for P. gingivalis-positive Alzheimer’s Disease
Groundbreaking Clinical Trial to Enroll 300 Patients in Double-Blind, Placebo-Controlled Study of Lysine-Gingipain Inhibitor SAN FRANCISCO, Aug. 22, 2025 /PRNewswire/... Read more.